Artículos de revistas
MYH9-related disease: Five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations
Fecha
2013-01Registro en:
de Rocco, Daniela; Zieger, Barbara; Platokouki, Helen; Heller, Paula Graciela; Pastore, Annalisa; et al.; MYH9-related disease: Five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations; Elsevier Masson; European Journal Of Medical Genetics; 56; 1; 1-2013; 7-12
1769-7212
Autor
de Rocco, Daniela
Zieger, Barbara
Platokouki, Helen
Heller, Paula Graciela
Pastore, Annalisa
Bottega, Roberta
Noris, Patrizia
Barozzi, Serena
Glembotsky, Ana Claudia
Pergantou, Helen
Balduini, Carlo L.
Savoia, Anna
Pecci, Alessandro
Resumen
MYH9-related disease (MYH9-RD) is a rare autosomal dominant syndromic disorder caused by mutations in MYH9, the gene encoding for the heavy chain of non-muscle myosin IIA (myosin-9). MYH9-RD is characterized by congenital macrothrombocytopenia and typical inclusion bodies in neutrophils associated with a variable risk of developing sensorineural deafness, presenile cataract, and/or progressive nephropathy. The spectrum of mutations responsible for MYH9-RD is limited. We report five families, each with a novel MYH9 mutation. Two mutations, p.Val34Gly and p.Arg702Ser, affect the motor domain of myosin-9, whereas the other three, p.Met847_Glu853dup, p.Lys1048_Glu1054del, and p.Asp1447Tyr, hit the coiled-coil tail domain of the protein. The motor domain mutations were associated with more severe clinical phenotypes than those in the tail domain.